Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”

HomeCirculationVol. 147, No. 12Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” No AccessLetterRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessFull TextLetter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study” Liling Deng, Yan Chen and Wuquan Deng Liling DengLiling Deng Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, China. *L. Deng and Y. Chen contributed equally. Search for more papers by this author , Yan ChenYan Chen Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, China. *L. Deng and Y. Chen contributed equally. Search for more papers by this author and Wuquan DengWuquan Deng https://orcid.org/0000-0002-5450-9713 Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, China. Search for more papers by this author Originally published21 Mar 2023https://doi.org/10.1161/CIRCULATIONAHA.122.062624Circulation. 2023;147:985–986"Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”." Circulation, 147(12), pp. 985–986Footnotes*L. Deng and Y. Chen contributed equally.Circulation is available at www.ahajournals.org/journal/circReferences1. Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, Kivimaki M. Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study.Circulation. 2022; 146:995–1005. doi: 10.1161/CIRCULATIONAHA.122.059430LinkGoogle Scholar2. Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016.JAMA Pediatr. 2020; 174:e194498. doi: 10.1001/jamapediatrics.2019.4498CrossrefMedlineGoogle Scholar3. Lu J, He J, Li M, Tang X, Hu R, Shi L, Su Q, Peng K, Xu M, Xu Y, et al; 4C Study Group. Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults.Diabetes Care. 2019; 42:1539–1548. doi: 10.2337/dc18-1390CrossrefMedlineGoogle Scholar4. Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, Close KL. Validation of time in range as an outcome measure for diabetes clinical trials.Diabetes Care. 2019; 42:400–405. doi: 10.2337/dc18-1444CrossrefMedlineGoogle Scholar5. Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, Amona RA, El Nahas K, Suleiman N, Alnaama A, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.Lancet Diabetes Endocrinol. 2020; 8:477–489. doi: 10.1016/S2213-8587(20)30117-0CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails March 21, 2023Vol 147, Issue 12 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.122.062624PMID: 36944035 Originally publishedMarch 21, 2023 PDF download Advertisement SubjectsCardiovascular DiseaseDiabetes, Type 1Diabetes, Type 2